Pfizer modifies protocol for virus vaccine study
It has received USFDA nod to include adolescents aged 12 to 15 in its global Covid-19 vaccine study13-10-2020
13-10-2020
Coronavirus vaccine: These Indian, US firms have entered last stage of clinical trials
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax12-10-2020
PFIZER LTD. - 500680 - Closure of Trading Window
Dear Sirs, Sub: Closure of Trading Window - Pfizer Limited We would like to inform you that, for the purpose of declaration of financial results for the quarter and half year ended September 30, 2020, the trading window of the Company shall remain closed from September 30, 2020 (close of business) till 48 hours after the results are made public. We request you to kindly take the above on record.30-09-2020
Pfizer urged to wait till November to seek COVID-19 vaccine authorisation
A letter which was obtained by Bloomberg Law and verified by six signatories, was sent on September 25 following the reports that Pfizer's COVID-19 vaccine clinical trial will yield conclusive results in October which puts the company ahead of Moderna and AstraZeneca in the race of the vaccine.26-09-2020
Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial
Pfizer's German development partner BioNTech on Thursday joined other leading Covid-19 vaccine developers in ruling out participation in British plans to test experimental inoculations25-09-2020
Stocks markets face a big test as covid vaccine results likely from next month
Late-stage data on trials of covid vaccines by companies such as Pfizer Inc and Moderna Inc possible as soon as October or November22-09-2020
Moderna and Pfizer reveal secret blueprints for virus vaccine trials
The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored19-09-2020
Pfizer's COVID-19 vaccine update | Candidate's trial report finds no major safety issues
Pfizer expects conclusive data by October-end and promised to make public all its safety and efficacy data in case of emergency authorisation for vaccine16-09-2020
Coronavirus vaccine in US by year-end if regulators approve candidate, says Pfizer CEO
According to Pfizer CEO Albert Bourla, the company's study will show if there is a good chance if the product works by October-end, distribution would depend on license issuances from regulators such as the FDA14-09-2020
PFIZER LTD. - 500680 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Pfizer Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here11-09-2020